Ex-vivo expanded umbilical cord blood stem cells retain capacity for myocardial regeneration

Circulation Journal

Volumn 74, Issue 1, 2010, Pages 188-194

  Schlechta, Bernhard ^a   Wiedemann, Dominik ^a   Kittinger, Clemens ^b   Jandrositz, Anita ^c   Bonaros, Nikolaos E ^a   Huber, Johannes C ^d   Preisegger, Karl Heinz ^c   Kocher, Alfred A ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c EccoCell Biotechnology Inc   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Myocardial repair; Stem cells; Umbilical cord blood

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; FLT3 LIGAND; INTERLEUKIN 6; STEM CELL FACTOR; THROMBOPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CORONARY ARTERY LIGATION; EX VIVO STUDY; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE REGENERATION; HEART VENTRICLE FUNCTION; HEMATOPOIETIC STEM CELL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; RAT; REGENERATION;

ANIMALS; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; CORONARY VESSELS; DISEASE MODELS, ANIMAL; HEART; HUMANS; INTERLEUKINS; LIGATION; MALE; MYOCARDIAL INFARCTION; RATS; RATS, INBRED STRAINS; REGENERATION;

EID: 75149181409     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0409     Document Type: Article

References (38)

1. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430-436.
2. Tatsumi T, Ashihara E, Yasui T, Matsunaga S, Kido A, Sasada Y, et al. Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circ J 2007; 71: 1199-1207.
3. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157-166.
4. Gluckman E. The therapeutic potential of fetal and neonatal hema topoietic stem cells. N Engl J Med 1996; 335: 1839-1840.
5. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-1577.
6. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962-2971.
7. McNiece IK. Ex vivo expansion of hematopoietic cells: What is the clinical need? J Hematother Stem Cell Res 2001; 10: 431-433.
8. Sato T, Laver JH, Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood 1999; 94: 2548-2554.
9. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998; 4: 1038-1045.
10. Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M. Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol 1998; 26: 353-360.
11. Nakamura Y, Ando K, Chargui J, Kawada H, Sato T, Tsuji T, et al. Ex vivo generation of CD34(+) cells from CD34(-) hematopoietic cells. Blood 1999; 94: 4053-4059.
12. Rutella S, Bonanno G, Marone M, De Ritis D, Mariotti A, Voso MT, et al. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7- CD45+lineage-cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15. J Immunol 2003; 171: 2977-2988.
13. Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M, Bhatia M. Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 2000; 95: 2813-2820.
14. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, et al. AC133: A novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002-5012.
15. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958.
16. Salven P, Mustjoki S, Alitalo R, Alitalo K, Rafii S. VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 2003; 101: 168-172.
17. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004; 114: 330-338.
18. Astori G, Malangone W, Adami V, Risso A, Dorotea L, Falasca E, et al. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use. Blood Cells Mol Dis 2001; 27: 715-724; discussion 725-727.
19. Encabo A, Mateu E, Carbonell-Uberos F, Minana MD. IL-6 precludes the differentiation induced by IL-3 on expansion of CD34+ cells from cord blood. Haematologica 2003; 88: 388-395.
20. Wagner T, Fritsch G, Thalhammer R, Hocker P, Lanzer G, Lechner K, et al. IL-10 increases the number of CFU-GM generated by ex vivo expansion of unmanipulated human MNCs and selected CD34+ cells. Transfusion 2001; 41: 659-666.
21. Keil F, Elahi F, Greinix HT, Fritsch G, Louda N, Petzer AL, et al. Ex vivo expansion of long-term culture initiating marrow cells by IL-10, SCF, and IL-3. Transfusion 2002; 42: 581-587.
22. Anklesaria P, Kase K, Glowacki J, Holland CA, Sakakeeny MA, Wright JA, et al. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation. Proc Natl Acad Sci USA 1987; 84: 7681-7685.
23. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18: 307-316.
24. Tatsumi K, Otani H, Sato D, Enoki C, Iwasaka T, Imamura H, et al. Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation. Circ J 2008; 72: 1351-1358.
25. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527-1536.
26. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997; 89: 2644-2653.
27. Donaldson C, Denning-Kendall P, Bradley B, Hows J. The CD34(+)CD38(neg) population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: Dissociation of phenotype and function. Bone Marrow Transplant 2001; 27: 365-371.
28. Bonanno G, Perillo A, Rutella S, De Ritis DG, Mariotti A, Marone M, et al. Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells. Transfusion 2004; 44: 1087-1097.
29. Lam AC, Li K, Zhang XB, Li CK, Fok TF, Chang AM, et al. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: Duration of culture, media, serum supplements, and growth factors used and engraftment in NOD/SCID mice. Transfusion 2001; 41: 1567-1576.
30. Ohishi K, Varnum-Finney B, Bernstein ID. Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells. J Clin Invest 2002; 110: 1165-1174.
31. Pasino M, Lanza T, Marotta F, Scarso L, De Biasio P, Amato S, et al. Flow cytometric and functional characterization of AC133+ cells from human umbilical cord blood. Br J Haematol 2000; 108: 793-800.
32. de Wynter EA, Buck D, Hart C, Heywood R, Coutinho LH, Clayton A, et al. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 1998; 16: 387-396.
33. Handgretinger R, Gordon PR, Leimig T, Chen X, Buhring HJ, Niethammer D, et al. Biology and plasticity of CD133+ hematopoietic stem cells. Ann NY Acad Sci 2003; 996: 141-151.
34. Pesce M, Orlandi A, Iachininoto MG, Straino S, Torella AR, Rizzuti V, et al. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ Res 2003; 93: e51-e62.
35. McGuckin CP, Forraz N, Allouard Q, Pettengell R. Umbilical cord blood Stem Cells can expand hematopoietic and neuroglial progenitors in vitro. Exp Cell Res 2004; 295: 350-359.
36. Forraz N, Pettengell R, Deglesne PA, McGuckin CP. AC133+ umbilical cord blood progenitors demonstrate rapid self-renewal and low apoptosis. Br J Haematol 2002; 119: 516-524.
37. Choi JH, Choi J, Lee WS, Rhee I, Lee SC, Gwon HC, et al. Lack of additional benefit of intracoronary transplantation of autologous peripheral blood stem cell in patients with acute myocardial infarction. Circ J 2007; 71: 486-494.
38. Kocher AA, Schuster MD, Bonaros N, Lietz K, Xiang G, Martens TP, et al. Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J Mol Cell Cardiol 2006; 40: 455-464.